JP2013528586A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528586A5
JP2013528586A5 JP2013508577A JP2013508577A JP2013528586A5 JP 2013528586 A5 JP2013528586 A5 JP 2013528586A5 JP 2013508577 A JP2013508577 A JP 2013508577A JP 2013508577 A JP2013508577 A JP 2013508577A JP 2013528586 A5 JP2013528586 A5 JP 2013528586A5
Authority
JP
Japan
Prior art keywords
alkyl
organic peroxide
sample
mono
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013508577A
Other languages
English (en)
Japanese (ja)
Other versions
JP6072677B2 (ja
JP2013528586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/001394 external-priority patent/WO2011138682A2/en
Publication of JP2013528586A publication Critical patent/JP2013528586A/ja
Publication of JP2013528586A5 publication Critical patent/JP2013528586A5/ja
Application granted granted Critical
Publication of JP6072677B2 publication Critical patent/JP6072677B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013508577A 2010-05-06 2011-05-06 微生物の不活化のための有機ペルオキシド化合物 Expired - Fee Related JP6072677B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
US61/395,117 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (3)

Publication Number Publication Date
JP2013528586A JP2013528586A (ja) 2013-07-11
JP2013528586A5 true JP2013528586A5 (https=) 2015-04-16
JP6072677B2 JP6072677B2 (ja) 2017-02-01

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013508577A Expired - Fee Related JP6072677B2 (ja) 2010-05-06 2011-05-06 微生物の不活化のための有機ペルオキシド化合物

Country Status (11)

Country Link
US (1) US9426989B2 (https=)
EP (1) EP2566323A2 (https=)
JP (1) JP6072677B2 (https=)
KR (1) KR20130079398A (https=)
CN (1) CN102946727B (https=)
AU (1) AU2011249487C1 (https=)
BR (1) BR112012028146A2 (https=)
CA (1) CA2796213A1 (https=)
EA (1) EA201291179A1 (https=)
MX (1) MX343948B (https=)
WO (1) WO2011138682A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
KR20220098370A (ko) 2019-11-07 2022-07-12 세퀴러스 유케이 리미티드 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127618C (https=) 1963-01-16
US3560395A (en) 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
DE2933498A1 (de) * 1979-08-18 1981-04-09 Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe Chemothermisches desinfektions- und sterilisationsverfahren
PH25669A (en) * 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) * 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) * 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) * 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB9612035D0 (en) * 1996-06-08 1996-08-07 Oilfield Chemical Additives Li Method of inhibiting reservoir souring by bacteria
DE19817743A1 (de) * 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) * 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
PL355287A1 (en) 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
KR100797547B1 (ko) 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) * 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
CA2438960A1 (en) 2001-02-23 2002-09-06 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
EP2281573A3 (en) 2001-02-23 2011-12-07 GlaxoSmithKline Biologicals s.a. Influenza vaccine formulations for intradermal delivery
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20030012804A1 (en) 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
WO2003014338A1 (en) * 2001-08-02 2003-02-20 Anges Mg, Inc. Process for producing inactivated virus envelope
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) * 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) * 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
BRPI0409752A (pt) * 2003-04-16 2006-05-09 Neochemical Desarrollos Avanza uso de um peróxido de dialquil cetona como um biocida: agente esterilizante, anti-séptico, desinfetante e anti-parasìtico e método de esterilização, desinfecção, assepsia ou eliminação de parasitas
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
JP2007537760A (ja) 2004-05-20 2007-12-27 アイディー バイオメディカル コーポレイション インフルエンザワクチンを製造するためのプロセス
DK2368975T3 (en) 2004-12-23 2015-01-05 Medimmune Llc Non-tumorigenic MDCK cell line for the propagation of viruses
GB0505909D0 (en) 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US8124397B2 (en) * 2005-08-08 2012-02-28 Oregon Health & Science University Inactivating pathogens with oxidizing agents for vaccine production
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
ES2525518T3 (es) 2005-11-01 2014-12-26 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
ES2286949B1 (es) * 2006-05-26 2008-11-01 Braulio Peña Rodriguez Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
PT2121011E (pt) 2006-12-06 2014-07-31 Novartis Ag Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe

Similar Documents

Publication Publication Date Title
JP2013528586A5 (https=)
Santry et al. Production and purification of high-titer Newcastle disease virus for use in preclinical mouse models of cancer
CN102181581B (zh) 犬瘟热病毒、肠炎细小病毒和阿留申病毒的三重pcr试剂盒
JP2016185988A5 (https=)
CA2848117A1 (en) Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
JP2013537518A5 (https=)
CA2796213A1 (en) Organic peroxide compounds for microorganism inactivation
Zhao et al. Enterovirus71 virus‐like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice
JP2012525837A5 (https=)
Ashmi et al. Molecular characterization of canine distemper virus from Tamil Nadu, India
JP2019501640A (ja) Rnaウイルスの採取装置および方法
Morimoto et al. Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity
JP2020503068A5 (https=)
Liao et al. Graphene oxide as a bifunctional material toward superior RNA protection and extraction
KR20140031912A (ko) 개 인플루엔자 재조합 바이러스 및 그 제조방법과 응용
EA201501099A3 (ru) Способ получения катионных амфифильных блок-сополимеров n, n-диметиламиноэтилметакрилата для доставки нуклеиновых кислот в живые клетки
CN104178459A (zh) 一种无血清悬浮培养狂犬病毒的方法
O’Connell et al. Humanized mice for live-attenuated vaccine research: From unmet potential to new promises
RS57864B1 (sr) Postupci za sprečavanje agregacije virusnih komponenti
PH12023550246A1 (en) Modified chikungunya viruses and sindbis viruses and uses thereof
JP2016086711A5 (https=)
CN102668903B (zh) Dna甲基化修饰剂在调控棉花纤维长度中的应用
CN114990075A (zh) 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用
RU2017105223A (ru) Аттенуированный штамм вируса репродуктивно-респираторного синдрома свиней (ррсс) и его возможное применение в средствах для иммунизации
CN109937259A (zh) 一种提高核酸聚合测序质量的方法、反应体系和试剂盒